2019 Q1 Form 10-Q Financial Statement

#000117184319002265 Filed on April 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $13.32M $12.21M
YoY Change 9.02% 39.7%
Cost Of Revenue $9.284M $8.013M
YoY Change 15.87% 36.5%
Gross Profit $4.031M $4.201M
YoY Change -4.04% 46.24%
Gross Profit Margin 30.28% 34.4%
Selling, General & Admin $4.469M $4.449M
YoY Change 0.44% 8.8%
% of Gross Profit 110.85% 105.9%
Research & Development $927.5K $922.7K
YoY Change 0.52% 24.35%
% of Gross Profit 23.01% 21.96%
Depreciation & Amortization $280.0K $280.0K
YoY Change 0.0% 21.74%
% of Gross Profit 6.95% 6.66%
Operating Expenses $5.396M $5.372M
YoY Change 0.46% 11.19%
Operating Profit $1.787M $2.244M
YoY Change -20.37% 268.64%
Interest Expense $3.835K $5.779K
YoY Change -33.64% 66.54%
% of Operating Profit 0.21% 0.26%
Other Income/Expense, Net
YoY Change
Pretax Income $1.800M $2.260M
YoY Change -20.35% 270.49%
Income Tax $246.4K $841.9K
% Of Pretax Income 13.69% 37.25%
Net Earnings $1.402M $1.333M
YoY Change 5.16% 244.44%
Net Earnings / Revenue 10.53% 10.91%
Basic Earnings Per Share $0.16 $0.29
Diluted Earnings Per Share $0.15 $0.29
COMMON SHARES
Basic Shares Outstanding 9.084M 4.537M
Diluted Shares Outstanding 9.448M 4.673M

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.160M $8.340M
YoY Change -26.14% 119.47%
Cash & Equivalents $4.936M $5.067M
Short-Term Investments $1.230M $3.270M
Other Short-Term Assets $1.460M $1.020M
YoY Change 43.14% 67.21%
Inventory $11.30M $9.126M
Prepaid Expenses $1.457M $1.025M
Receivables $10.01M $8.760M
Other Receivables $1.850M $1.670M
Total Short-Term Assets $30.79M $28.92M
YoY Change 6.47% 42.27%
LONG-TERM ASSETS
Property, Plant & Equipment $7.229M $7.156M
YoY Change 1.03% -4.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.42M $22.26M
YoY Change 9.7% 5.7%
Other Assets $153.8K
YoY Change
Total Long-Term Assets $34.31M $24.56M
YoY Change 39.7% 2.42%
TOTAL ASSETS
Total Short-Term Assets $30.79M $28.92M
Total Long-Term Assets $34.31M $24.56M
Total Assets $65.10M $60.63M
YoY Change 7.36% 17.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.307M $4.266M
YoY Change 0.97% 19.64%
Accrued Expenses $2.290M $2.120M
YoY Change 8.02% 51.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.608M $6.724M
YoY Change -1.73% 35.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.608M $6.724M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $9.620M $9.630M
YoY Change -0.1% 28.4%
SHAREHOLDERS EQUITY
Retained Earnings $43.77M $38.59M
YoY Change 13.44% 12.37%
Common Stock $15.44M $14.49M
YoY Change 6.6% 3.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.47M $51.00M
YoY Change
Total Liabilities & Shareholders Equity $65.10M $60.63M
YoY Change 7.36% 17.07%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income $1.402M $1.333M
YoY Change 5.16% 244.44%
Depreciation, Depletion And Amortization $280.0K $280.0K
YoY Change 0.0% 21.74%
Cash From Operating Activities $1.000M $910.0K
YoY Change 9.89% 810.0%
INVESTING ACTIVITIES
Capital Expenditures -$380.0K -$130.0K
YoY Change 192.31% -75.0%
Acquisitions
YoY Change
Other Investing Activities $480.0K $500.0K
YoY Change -4.0% -50.0%
Cash From Investing Activities $120.0K $370.0K
YoY Change -67.57% -22.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -750.0K -910.0K
YoY Change -17.58% 1037.5%
NET CHANGE
Cash From Operating Activities 1.000M 910.0K
Cash From Investing Activities 120.0K 370.0K
Cash From Financing Activities -750.0K -910.0K
Net Change In Cash 370.0K 370.0K
YoY Change 0.0% -26.0%
FREE CASH FLOW
Cash From Operating Activities $1.000M $910.0K
Capital Expenditures -$380.0K -$130.0K
Free Cash Flow $1.380M $1.040M
YoY Change 32.69% 67.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2018Q1 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2018Q3 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
25812637
ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
65234
ntic Allocated Share Based Compensation Expense Estimate Next Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear
715961
CY2019Q1 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
27077441
CY2019Q1 ntic Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage
0.775
CY2018Q3 ntic Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage
0.741
CY2019Q1 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1436774
CY2018Q1 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1608890
ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
2865209
ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
3116032
CY2019Q1 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1338493
CY2018Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1357255
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-18762
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
62381
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
-730647
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
2292004
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-82157
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-244372
CY2019Q1 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
12606449
CY2018Q1 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
11399853
ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
26217314
CY2018Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6927484
ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
22435260
CY2019Q1 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
708955
CY2018Q1 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
814122
ntic Net Sales To Joint Ventures
NetSalesToJointVentures
1192142
ntic Net Sales To Joint Ventures
NetSalesToJointVentures
1321753
ntic Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2019Q1 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1436774
CY2018Q1 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1608890
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
2865209
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
3116032
CY2019Q1 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
9329725
CY2018Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
9920108
CY2019Q1 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
679349
CY2018Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
761506
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4307450
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3905034
CY2019Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
900000
CY2018Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
880000
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8555
CY2018Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
70892
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5158013
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4749095
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3742258
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3597199
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15353400
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14619777
us-gaap Adjustment For Amortization
AdjustmentForAmortization
129346
us-gaap Adjustment For Amortization
AdjustmentForAmortization
125092
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
357980
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
103267
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
715960
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
206534
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
65000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
50000
CY2019Q1 us-gaap Assets
Assets
65095033
CY2018Q3 us-gaap Assets
Assets
63549236
CY2019Q1 us-gaap Assets Current
AssetsCurrent
30788194
CY2018Q3 us-gaap Assets Current
AssetsCurrent
30567773
CY2019Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1227268
CY2018Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3300110
CY2019Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1227268
CY2018Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3300110
CY2019Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
7334574
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4163023
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6360201
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4936377
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5067087
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
773354
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1293114
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2018Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4542177
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4541303
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4542177
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4541303
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
90844
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
90826
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1577395
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1780338
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2753568
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2816785
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
169499
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
109047
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
336699
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
245962
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1746894
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1889385
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3090267
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3062747
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9284099
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8012836
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18745236
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15901306
CY2019Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1420791
CY2018Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1551536
us-gaap Depreciation
Depreciation
429377
us-gaap Depreciation
Depreciation
418562
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0%"></td> <td style="width: 5%"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></td> <td style="width: 95%">ACCOUNTING PRONOUNCEMENTS</td> </tr> </table> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">New Accounting Pronouncements Adopted</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#x2019;s significant accounting policies are detailed in &#x201c;Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div> Nature of Business and Significant Accounting Policies&#x201d; of the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 31, 2018. </div>In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued guidance creating Accounting Standards Codification (ASC) Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div> (ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>), which establishes a comprehensive new model for the recognition of revenue from contracts with customers. This model is based on the core principle that revenue should be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 1, 2018, </div>the Company adopted ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> for all customer contracts using the modified retrospective method. To determine revenue recognition for arrangements within the scope of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> the Company performs the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contracts with a customer; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligations in the contract; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price; (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract; and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when or as the entity satisfies a performance obligation. The Company only applies the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods it transfers to, or services it performs for, the customer.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> neither impacted the previously reported financial statements in any prior period nor did it result in a cumulative effect adjustment to retained earnings. Therefore, the adoption of the standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> impact the Company&#x2019;s revenue recognition process. Generally, the Company&#x2019;s performance obligations are satisfied when the customers take possession of the products, which normally occurs at the shipping point or destination depending on the terms of the contracts. The Company&#x2019;s services are generally sold based upon quotes or contracts with customers that include a fixed or determinable price, and sales arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contain any significant financing component for its customers. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> recognize revenue related to product warranties, nor does the Company incur significant contract costs. Customer arrangements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate contract assets or liabilities.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 --> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes to the Company&#x2019;s significant accounting policies as a result of adopting ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> are discussed below:</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Revenue Recognition</div> - Revenue is measured based on consideration specified in the contract with a customer, adjusted for any applicable estimates of variable consideration and other factors affecting the transaction price, including noncash consideration, consideration paid or payable to customers, and significant financing components. While most of the Company&#x2019;s revenue is contracted with customers through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time purchase orders and short-term contracts, the Company does have long-term arrangements with certain customers. Revenue from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to a customer.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Individually promised goods and services in a contract are considered a distinct performance obligation and accounted for separately if the customer can benefit from the individual good or service on its own or with other resources that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement. When an arrangement includes multiple performance obligations, the consideration is allocated between the performance obligations in proportion to their estimated standalone selling price. Costs related to products delivered are recognized in the period incurred, unless criteria for capitalization of costs are met. Costs of revenues consist primarily of direct labor, manufacturing overhead, materials, and components. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> incur significant upfront costs to obtain a contract. If costs to obtain a contract were to become material, the costs would be recorded as an asset and amortized to expense in a manner consistent with the related recognition of revenue.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company excludes government assessed and imposed taxes on revenue generating transactions that are invoiced to customers from revenue. The Company includes freight billed to customers in revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of goods sold.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The timing of revenue recognition, billings, and cash collections results in accounts receivable on the balance sheet.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Performance Obligations</div> - A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract&#x2019;s transaction price is allocated to each distinct performance obligation in proportion to its standalone selling price and recognized as revenue when, or as, the performance obligation is satisfied. The Company&#x2019;s various performance obligations and the timing or method of revenue recognition are discussed below.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company sells its products to both distributors and end-users. Each unit of product delivered under a customer order represents a distinct and separate performance obligation, as the customer can benefit from each unit on its own or with other resources that are readily available to the customer, and each unit of product is separately identifiable from other products in the arrangement.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 10; Value: 1 --> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transaction price for the Company&#x2019;s products is the invoiced amount. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have variable consideration in the form of refunds, credits, rebates, price concessions, pricing incentives, or other items impacting transaction price. The purchase order pricing in arrangements with customers is deemed to approximate standalone selling price; therefore, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> need to allocate proceeds on a relative standalone selling price allocation between performance obligations. The Company applies the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose information about remaining performance obligations that have original expected durations of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material obligations that extend beyond <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue is recognized when transfer of control occurs as defined by the terms in the customer agreement. The Company immediately recognizes incidental items that are immaterial in the context of the contract. The Company has applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16A</div> and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> assess if immaterial items are promised goods or services. The Company has also applied the practical expedient in paragraph <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> regarding the adjustment of the promised amount of consideration for the effects of a significant financing component when the customer pays for that good or service within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less, as the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any significant financing components in its customer arrangements since payment is received at or shortly after the point of sale, generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ninety</div> days.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company estimates returns based on an analysis of historical experience if the right to return products is granted to its customers. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> record a return asset, as non-conforming products are generally <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> returned. The Company&#x2019;s return policy does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> vary by geography. The customer has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> rotation or price protection rights, and the Company is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> under a warranty obligation.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Trade Receivables</div> - Trade receivables include amounts invoiced and currently due from customers. The amounts due are stated at their net estimated realizable value. The Company records an allowance for doubtful accounts to provide for the estimated amount of receivables that will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be collected. The allowance is based on a review of all outstanding amounts on an on-going basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considers a customer&#x2019;s financial condition, credit history, and current economic conditions. Trade receivables are written off when deemed uncollectible and have been historically insignificant. Recoveries of trade receivables previously written off are recorded when received. Accounts are considered past due if payment is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> received according to agreed-upon terms.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Sales Commissions</div> - Sales commissions paid to sales representatives are eligible for capitalization, as they are incremental costs that would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have been incurred without entering into a specific sales arrangement and are recoverable through the expected margin on the transaction. The Company has elected to apply the practical expedient provided by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">340</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> and recognize the incremental costs of obtaining contracts as an expense when incurred, as the amortization period of the assets that would have otherwise been recognized is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. The Company records these costs as a selling expense.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Product Warranty</div> - The Company offers warranties on various products and services. These warranties are assurance type warranties that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> sold on a standalone basis; therefore, they are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> considered distinct performance obligations. The Company estimates the costs that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be incurred under its warranties and records a liability in the amount of such costs at the time the revenue is recognized for the product sale.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">International Revenue</div> - The Company markets its products to numerous countries in North America, Europe, Latin America, Asia, and other parts of the world. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> Segment and Geographical Information, for information regarding revenue disaggregation by geography.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 11; Value: 1 --> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Recently Issued Accounting Pronouncements</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases</div>. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years, with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The guidance will be effective for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> The Company is currently assessing the effect that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Income Statement &#x2013; Reporting Comprehensive Income (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220</div>) Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</div>, which will allow a reclassification from accumulated other comprehensive income to retained earnings for the tax effects resulting from the Tax Cuts and Jobs Act (Tax Reform Act) that are stranded in accumulated other comprehensive income. This standard also requires certain disclosures about stranded tax effects. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> however, does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> change the underlying guidance that requires that the effect of a change in tax laws or rates be included in income from continuing operations. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will be effective for the Company&#x2019;s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020,</div> with the option for early adoption at any time prior to the effective date. It must be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. The Company is currently assessing the impact this new accounting guidance will have on its consolidated financial statements.</div></div>
CY2018Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2018-11-21
CY2019Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2019-02-22
CY2017Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2017-12-21
CY2018Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2018-02-21
CY2019Q1 us-gaap Dividends
Dividends
545064
CY2018Q1 us-gaap Dividends
Dividends
452514
us-gaap Dividends
Dividends
1090125
us-gaap Dividends
Dividends
907252
CY2018Q4 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2018-10-24
CY2019Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2019-01-23
CY2017Q4 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2017-11-20
CY2018Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2018-01-24
CY2018Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2018-11-07
CY2019Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2019-02-06
CY2017Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2017-12-08
CY2018Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2018-02-08
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
74068
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
55894
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1137209
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2747303
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
781195
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2027243
CY2018 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6377054
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
65423178
CY2018Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
62803261
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
60831022
CY2018Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
58086747
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
15529788
CY2018Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
15991886
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
49462712
CY2018Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
46407722
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
12632547
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
25989438
CY2018Q1 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
13531276
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
26319398
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
3450976
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
7614767
CY2018Q1 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
3712684
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
7212499
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
430678
CY2018Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
403653
CY2019Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
27749880
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
58229806
CY2018Q1 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
30220550
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
58719261
CY2019Q1 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
24418491
CY2018Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
22950995
CY2019Q1 us-gaap Equity Method Investments
EquityMethodInvestments
24418491
CY2018Q3 us-gaap Equity Method Investments
EquityMethodInvestments
22950995
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1084313
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1156257
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
36285
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1963537
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1805216
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4459334
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4024961
CY2019Q1 us-gaap Gross Profit
GrossProfit
4031305
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
246371
CY2018Q1 us-gaap Gross Profit
GrossProfit
4201139
us-gaap Gross Profit
GrossProfit
8664220
us-gaap Gross Profit
GrossProfit
7855707
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1715216
CY2018Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1805997
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3719378
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3547325
CY2019Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1798427
CY2018Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
2263532
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
3695321
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
3567112
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
502074
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
841909
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
946900
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
53975
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
53975
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
45000
CY2019Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
515448
CY2018Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
273333
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
113849
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1669859
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-32500
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
139991
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1517466
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-193647
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-135167
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-700000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
174502
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
178998
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2048648
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1631734
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-215178
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
504848
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
181753
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
135930
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
189433
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
103674
CY2019Q1 us-gaap Interest Expense
InterestExpense
3835
CY2018Q1 us-gaap Interest Expense
InterestExpense
5779
us-gaap Interest Expense
InterestExpense
6192
us-gaap Interest Expense
InterestExpense
10868
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
3835
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
5779
us-gaap Interest Paid Net
InterestPaidNet
6192
us-gaap Interest Paid Net
InterestPaidNet
10868
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9196302
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7306372
CY2019Q1 us-gaap Inventory Gross
InventoryGross
11304475
CY2018Q3 us-gaap Inventory Gross
InventoryGross
9130861
CY2019Q1 us-gaap Inventory Net
InventoryNet
11304475
CY2018Q3 us-gaap Inventory Net
InventoryNet
9130861
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2108173
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1824489
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15122
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
24883
us-gaap Investment Income Interest
InvestmentIncomeInterest
27909
us-gaap Investment Income Interest
InvestmentIncomeInterest
48939
CY2019Q1 us-gaap Land
Land
310365
CY2018Q3 us-gaap Land
Land
310365
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65095033
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63549236
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6608162
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7730182
CY2019Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4742472
CY2018Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4680072
CY2019Q1 us-gaap Minority Interest
MinorityInterest
3013042
CY2018Q3 us-gaap Minority Interest
MinorityInterest
2742309
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
200000
CY2018Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
200000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1138409
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1079396
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1575542
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
246587
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
262153
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-516199
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1401568
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1332847
us-gaap Net Income Loss
NetIncomeLoss
2898627
us-gaap Net Income Loss
NetIncomeLoss
2416473
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
150488
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
88776
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
294620
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
203739
CY2019Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
134034
CY2019Q1 us-gaap Noncurrent Assets
NoncurrentAssets
7229398
CY2018Q3 us-gaap Noncurrent Assets
NoncurrentAssets
7168826
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
5396155
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
5371598
us-gaap Operating Expenses
OperatingExpenses
11575203
us-gaap Operating Expenses
OperatingExpenses
10990023
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1787140
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2244428
us-gaap Operating Income Loss
OperatingIncomeLoss
3673604
us-gaap Operating Income Loss
OperatingIncomeLoss
3529041
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1154948
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1006953
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
153846
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
153849
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
194838
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
467762
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-102980
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
442535
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
194838
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
467762
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-102980
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-102980
CY2019Q1 us-gaap Other Operating Income
OtherOperatingIncome
3151990
CY2018Q1 us-gaap Other Operating Income
OtherOperatingIncome
3414887
us-gaap Other Operating Income
OtherOperatingIncome
6584587
us-gaap Other Operating Income
OtherOperatingIncome
6663357
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1090125
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
907252
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
57401
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
44621
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
439899
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
207350
CY2019Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2018Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1457059
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1661577
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
2027243
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
1770116
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
134035
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2072842
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
498558
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15375
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
17681
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
12481
CY2019Q1 us-gaap Profit Loss
ProfitLoss
1552056
CY2018Q1 us-gaap Profit Loss
ProfitLoss
1421623
us-gaap Profit Loss
ProfitLoss
3193247
us-gaap Profit Loss
ProfitLoss
2620212
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12387411
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11917921
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7229398
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7168826
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
927537
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
922746
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1799694
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1721477
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4936377
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4163023
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43771843
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
41963341
CY2019Q1 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
22389278
CY2018Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
20921783
CY2019Q1 us-gaap Revenues
Revenues
13315404
CY2018Q1 us-gaap Revenues
Revenues
12213975
us-gaap Revenues
Revenues
27409456
us-gaap Revenues
Revenues
23757013
CY2019Q1 us-gaap Selling Expense
SellingExpense
2505081
CY2018Q1 us-gaap Selling Expense
SellingExpense
2643636
us-gaap Selling Expense
SellingExpense
5316175
us-gaap Selling Expense
SellingExpense
5243585
us-gaap Share Based Compensation
ShareBasedCompensation
715960
us-gaap Share Based Compensation
ShareBasedCompensation
206534
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0132
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0218
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.458
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.459
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0275
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70884
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
47252
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y146D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y273D
CY2018Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
874
CY2017Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
891
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1500
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
CY2018Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17681
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12481
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15375
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
715960
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
206534
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
55473829
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
53076745
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58486871
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55819054
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57127057
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
52367819
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53907961
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51718076
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4723930
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4673338
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4731608
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4641042
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4542177
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4537408
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4542175
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4537368

Files In Submission

Name View Source Status
0001171843-19-002265-index-headers.html Edgar Link pending
0001171843-19-002265-index.html Edgar Link pending
0001171843-19-002265.txt Edgar Link pending
0001171843-19-002265-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_040819p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lynchsig.jpg Edgar Link pending
ntic-20190228.xml Edgar Link completed
ntic-20190228.xsd Edgar Link pending
ntic-20190228_cal.xml Edgar Link unprocessable
ntic-20190228_def.xml Edgar Link unprocessable
ntic-20190228_lab.xml Edgar Link unprocessable
ntic-20190228_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wolsfeldsig.jpg Edgar Link pending